Over the next five years our BRC will continue its mission to discover new disease biomarkers and develop novel advanced therapeutics.

HPR11

This third consecutive award from the NIHR puts the BRC at Guy’s and St Thomas’ and King’s College London in position to lead the revolution in advanced therapeutics, and to play an enhanced role in ensuring that the UK is recognised as the best place in the world to conduct experimental medicine for the benefit of patients.